Esra Bilici

Dr. Esra Bilici

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2025 in Journal of King Saud University – Science
Verified
Journal Article
Open access
EBEsra Bilici
Esra Bilici
SASenem Akkoc
Senem Akkoc
HepG2 is crucial in liver research because of its distinctive characteristics and significant applicability in drug metabolism, hepatotoxicity, and liver diseases. Benzimidazole derivatives are potential medicinal agents for the treatment of liver cancer. A new benzimidazole-based compound was created and verified using 1H NMR, 13C NMR, and IR. We assessed the effects of a novel benzimidazole salt compound 3 on HepG2, DLD-1, MCF-7, and HEK-293T cells in culture. Compound 3 was administered to each of the three cancer cell lines for 72 hours, and the IC50 values were recorded. The IR, ADMET, real-time PCR, and the MTT assay were used to examine the effects of 3. The viabilities of MCF-7, HepG2, and DLD-1 cells after 72 hours were 22.41 µM, 25.14 µM, and 41.97 µM, respectively. In HepG2 cells, the expression levels of many molecules relevant to pathways were measured in terms of mRNA and protein. Compound 3 exhibited significant cytotoxicity, with IC50 values of 25.14 µM for HepG2, 22.41 µM for MCF-7, and 41.97 µM for DLD-1 cells, demonstrating selectivity toward cancer cells. Real-time PCR revealed elevated expression levels of pro-apoptotic markers (BAX, CASPASE-3, and CASPASE-8) and anti-apoptotic marker BCL-2, suggesting the induction of both intrinsic and extrinsic apoptotic pathways. The ADMET analysis highlighted favorable pharmacokinetic properties, including blood-brain barrier permeability and high gastrointestinal absorption. The novel benzimidazole compound 3 demonstrated significant anticancer activity and apoptotic potential in vitro, particularly against HepG2 cells. Its favorable ADMET profile and mechanism of action suggest its potential as a therapeutic agent for liver cancer. Future studies should focus on in vivo validation and further optimization of its pharmacological properties.

30 October 2025 in Turkish Journal of Veterinary Research
Verified
Journal Article
Open access
EAElif Ece Akgün
Elif Ece Akgün
EBEsra Bilici
Esra Bilici
Objective: Synovial fluid-derived mesenchymal stem cells represent a minimally invasive and highly proliferative source of multipotent cells with emerging potential in regenerative medicine. While their mesodermal differentiation is established, limited data exist on their neurogenic differentiation potential in rabbits. This study aimed to isolate and characterize rabbit synovial fluid mesenchymal stem cells and assess their capacity for neurogenic differentiation in vitro. Materials and Methods: Cells were isolated from rabbit knee synovial fluid, cultured, and confirmed to express typical mesenchymal stem cell surface markers. After neurogenic differentiation process, cells also were confirmed with ENOS2, MAP2 and Nestin markers. Results: Following neurogenic induction, synovial fluid mesenchymal stem cells displayed neuron-like morphology and upregulated neural markers, including Nestin, ENO2, and MAP2, as confirmed by Real Time-PCR. For mesenchymal stem cell identification, compare to control group CD 44, CD 73, CD90 and CD 105 genes were upregulated while CD 34 and CD 45 genes were downregulated. Conclusion: These results demonstrate the neurogenic potential of rabbit synovial fluid mesenchymal stem cells and support their application in preclinical models for neural repair.

1 January 2023 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
ÖGÖzay Güleş
Özay Güleş
EBEsra Bilici
Esra Bilici
EKEmira Kurbasevic
Emira Kurbasevic
ÖLÖmer Faruk Lenger
Ömer Faruk Lenger
MBMurat Boyacioğlu
Murat Boyacioğlu
EEErkmen Tuğrul EPİKMEN
Erkmen Tuğrul EPİKMEN
Purpose: Intracellular calcium (Ca2+) signaling plays a role in many cellular events, such as cell proliferation and differentiation, gene transcription, oxidative stress, the antioxidant system, and apoptosis. Transient receptor potential vanilloid 4 (TRPV4) channels are non-selective cation (Ca2+) channels. The present study aims to investigate the cytotoxic activity of RN-1734, a transient receptor potential vanilloid 4 (TRPV4) antagonist, in the G361 human melanoma cancer cell line. Materials and Methods: The effects of RN-1734 on G361 cell viability at concentrations of 1, 5, 25, 50, and 100 μM were measured using the 3-(4,5-dimethylthiazol-2-il)-2,5-diphenyltetrazolium bromide (MTT) method. Total antioxidant status (TAS) and total oxidant status (TOS) levels were determined using a ready-made commercial kit, after which oxidative stress index (OSI) values were calculated. To determine the apoptotic effects of RN-1734, Bcl-2, Bax, and p53 expression levels, caspase-3 and -8 activities were examined via quantitative real-time PCR analysis. Results: G361 cell viability significantly decreased to 82.72, 72.81, 56.36, 39.16 and 18.96% in RN-1734 groups (1, 5, 25, 50 and 100 μM) compared to the control group (100.00%). At IC50 concentration (39.48 μM), RN-1734 application (3.35 mmol/g prot.-TAS, 45.87 μmol/g prot.-TOS, and 1501.97 AU-OSI) increased the TAS level (2.17 mmol/g prot.) and decreased the TOS level (55.41 μmol/g prot.) and OSI value (3142.76 AU) compared to the control group. Conclusion: Our findings show that RN-1734 may be a novel therapeutic approach to treating melanoma by decreasing the cell viability of G361 human melanoma cancer cells.

26 May 2026 in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
Verified
Journal Article
Closed access
EBEsra Bilici
Esra Bilici
SASenem Akkoç
Senem Akkoç
Objective: The study focused on examining the cytotoxic and antiproliferative effects of ferulic acid (FA) on DLD-1 human colorectal adenocarcinoma cells.Methods: The DLD-1 cells were treated with increasing concentrations of ferulic acid (FA) ranging from 7.5 to 120 µM. The MTT test was used to determine cell viability in order to assess the dose-dependent effects of FA on cell proliferation. This experimental approach centered on detecting alterations in metabolic activity as a marker of cytotoxicity after FA treatment.Results: Treatment with FA resulted in a reduction in cell viability in a concentration-dependent manner. While lower concentrations (7.5-30 µM) showed no distinct cytotoxic effects, the highest tested concentration of significantly decreased the viability of DLD-1 cells to approximately 40%. These findings indicate that FA exerts a potent, dose-dependent antiproliferative activity, with the estimated IC50 value falling between 60 and 120 µM. Consequently, a clear dose-response relationship was established between FA concentration and tumor cell growth inhibition.Conclusion: Ferulic acid demonstrates a dose-dependent cytotoxic effect on DLD-1 colorectal cancer cells, supporting its potential as a complementary therapeutic agent in colorectal cancer treatment. To clarify the underlying molecular pathways and assess its effectiveness in in vivo models, more research is required.

7 April 2026 in Toxicology and Industrial Health
Verified
Journal Article
Closed access
ÖGÖzay Güleş
Özay Güleş
SKSadiye Kum
Sadiye Kum
ZNZahid Naseer
Zahid Naseer
MBMurat Boyacioglu
Murat Boyacioglu
EAEmine Ozel Armutoglu
Emine Ozel Armutoglu
UEUlker Eren
Ulker Eren
4-Nonylphenol (4-NP), an endocrine disruptor, is known to induce mutagenic, toxic, or carcinogenic effects, including testicular toxicity via inducing oxidative stress and apoptosis. The objective of this work was to determine the capacity of lycopene (LC) and gallic acid (GA) to protect testicular histological structure, biochemical responses, and semen parameters in rats exposed to 4-NP. In this 28-day dietary trial, six groups (n= 6 per group) received treatment via oral gavage: a control (corn oil, 2 mL/kg/day), LC (10 mg/kg body weight (BW)/day), GA (50 mg/kg BW/day), 4-NP (125 mg/kg BW/day), LC + 4-NP (LC followed by 4-NP), and GA + 4-NP (GA followed by 4-NP) groups. The results indicated that 4-NP administration adversely affects the final body weight, testicular histology, seminiferous epithelium heights (SEHs) (4-NP: 57.95 ± 0.49, p : 0.000), follicle-stimulating hormone (FSH) level, testis antioxidant capacity, testis malondialdehyde (MDA) level, and sperm viability and morphology. LC and GA supplementation significantly improved SEHs, activities of testis superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH), and sperm viability compared to the 4-NP group. Moreover, LC and GA exposures decreased histopathological lesions, including germinal epithelial degeneration, vacuolization, immature germ cells in the tubular lumen, and congestion in the interstitial area. Furthermore, they lowered TUNEL-positive cell counts and tubule percentages, testicular MDA levels, and abnormal sperm percentages. To our knowledge, this study provides one of the first systematic comparisons of lycopene and gallic acid in protecting against 4-NP-induced testicular toxicity under identical experimental conditions. The findings suggest that both compounds preserve testicular structure and function through their antioxidant and anti-apoptotic properties.

30 June 2025 in Dicle Üniversitesi Veteriner Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
EBEsra Bilici
Esra Bilici
BTBüşra Gülbenli Türkoğlu
Büşra Gülbenli Türkoğlu
SASenem Akkoç
Senem Akkoç
Cancer is known as a major health problem globally. Breast cancer is the most common malignant tumor and metastasis continues to be the main cause of poor prognosis. Despite recent advances in cancer treatment, the success of metastatic breast cancer treatment is not at the desired level. Among the anticancer drugs discovered in recent years, various benzimidazole derivatives have attracted attention in the development of anticancer agents due to their various biological activities and clinical applications. The aim of this study was to evaluate the antiproliferative activity of synthesized benzimidazole derivative SA-61 in 4T1 breast cancer cell line in comparison with abemaciclib, which is approved by FDA for the treatment of breast cancer. The antiproliferative activity and apoptotic effect of SA-61 were examined using MTT and immunohistochemical methods, respectively. According to MTT results, compound SA-61 showed antiproliferative activity in 4T1 cells in a dose-dependent manner, but this effect was lower than abemaciclib. Although further studies are needed to specifically identify the compounds involved in its anti-cancer activity, our findings suggest that SA-61 inhibits the proliferation of 4T1 cells and its effect is dose dependent.